320
Participants
Start Date
November 30, 2004
Primary Completion Date
August 31, 2006
Study Completion Date
August 31, 2006
Licarbazepine
Investigational Site, Philadelphia
Investigational Site, Dijon
Investigational Site, Raleigh
Investigational Site, Port Charlotte
Investigational Site, Cincinnati
Investigational Site, Indianapolis
Investigational Site, Strasbourg
Investigational Site, Newton
Investigational Site, Little Rock
Investigational Site, Oklahoma City
Investigational Site, Houston
Investigational Site, Houston
Investigational Site, Bellaire
Investigational Site, Austin
Investigational Site, Las Vegas
Investigational Site, Cerritos
Investigational Site, San Diego
Investigational Site, Kirkland
Investigational Site, Moscow
Investigational Site, Moscow
Investigational Site, Moscow
Investigational Site, Saint Petersburg
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY